Telogia Pharm, LLC

CIK 1839822 · View on SEC EDGAR ↗

Insider

First SEC filing: Feb. 4, 2021 · Latest: Feb. 14, 2022

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 2 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
April 9, 2021 TRLV J 15,415 85,918 Direct -15.21% Disposed (price as of 2026-08-20)
April 9, 2021 TRLV J 16,333 85,000 Direct -16.12% Disposed (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
April 9, 2021 TRLV Multiple Voting Shares [F1] Subordinate Voting Shares (1,541,500) 15,415 Disposed
April 9, 2021 TRLV Multiple Voting Shares [F1] Subordinate Voting Shares (1,633,300) 16,333 Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Feb. 4, 2021 TRLV Super Voting Shares→ Subordinate Voting Shares (10,133,300) 10,133,300 Direct